| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 6 | |
| #2 | EPO (European Patent Office) | 4 | |
| #3 | United States | 3 | |
| #4 | China | 2 | |
| #5 | Japan | 2 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Measurement | |
| #4 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Analysing materials | |
| #4 | Medical preparations | |
| #5 | Microorganisms | |
| #6 | Climate change mitigation in goods production |
| # | Name | Total Patents |
|---|---|---|
| #1 | Kurosawa Yoshikazu | 14 |
| #2 | Akahori Yasushi | 10 |
| #3 | Azuma Masachika | 8 |
| #4 | Kurosawa Gene | 7 |
| #5 | Suzuki Kazuhiro | 7 |
| #6 | Hayashi Nobuhiro | 6 |
| #7 | Matsuda Kazuki | 5 |
| #8 | Sugioka Atsushi | 5 |
| #9 | Sumitomo Mariko | 5 |
| #10 | Morita Miwa | 5 |
| Publication | Filing date | Title |
|---|---|---|
| WO2009096162A1 | Composition for neutralizing botulinus toxin type-a, and human anti-botulinus toxin type-a antibody | |
| CN101137671A | Anti-igsf4 antibody and utilization of the same | |
| JP2005160433A | Method for producing protein by using cell-free protein synthesis system | |
| JP2006180708A | Method for preparation of antibody | |
| US2005037421A1 | Methods of constructing camel antibody libraries | |
| EP1429143A1 | Method of selecting binding molecule |